000			03838cam a2200565 i 4500
001			ocn852690568
003			OCoLC
005			20221128212313.0
006			m d
007			cr |||||||||||
008			130221s2013 nyu ob 001 0 eng
010			_a 2019721880
040			_aDLC _beng _erda _cDLC _dYDXCP _dOCLCF _dEBLCP _dZ5A _dAU@ _dSTF _dN$T
016	7		_a016437354 _2Uk
020			_z9781626183612 _q(pbk.)
020			_z1626183619 _q(pbk.)
020			_a9781626183629 _qepub
020			_a1626183627
035			_a597380 _b(N$T)
035			_a(OCoLC)852690568
042			_apcc
072		7	_aHEA _x039100 _2bisacsh
072		7	_aMED _x065000 _2bisacsh
072		7	_aMED _x083000 _2bisacsh
049			_aMAIN
245	0	0	_aAnkylosing spondylitis : _bsymptoms, treatment and potential complications _c _h[E-Book]
264		1	_aNew York : _bNova Biomedical, _c[2013]
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aMuscular system--anatomy, functions and injuries
504			_aIncludes bibliographical references and index.
588			_aDescription based on print version record.
505	0		_aANKYLOSING SPONDYLITIS: SYMPTOMS, TREATMENT AND POTENTIAL COMPLICATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: OSTEOPOROSIS AND VERTERBAL FRACTURES IN ANKYLOSING SPONDYLITIS CURRENT CONCEPTS AND THERAPEUTIC CHALLENGES; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY OF OSTEOPOROSIS IN AS; RISK FACTORS FOR OSTEOPOROSIS AND LOW BMD IN AS; VERTEBRAL OSTEOPOROTIC FRACTURES; FACTORS ASSOCIATED WITH VERTEBRAL OSTEOPOROTIC FRACTURES; BASIC CONCEPTS OF MOLECULAR ASPECTS OF BONE; CYTOKINES AND BONE; BMD IN AS; GUIDELINES FOR BMD MEASUREMENT IN AS.
505	8		_aBONE REMODELING BIOMARKERSMARKERS OF BONE FORMATION; MARKERS OF BONE RESORPTION; CLINICAL APPLICATIONS OF BONE REMODELING MARKERS: PREDICTION OF BONE LOSS AND RESPONSE TO TREATMENT; DIAGNOSIS OF VERTEBRAL FRACTURES; DEFINITION OF VERTEBRAL FRACTURES; SITES OF VERTEBRAL FRACTURES IN AS; COMPLICATIONS OF VERTEBRAL FRACTURES; EFFECTS OF DRUGS USED FOR AS ON THE BMD: ANTI-TNF AGENTS AND BMD; MANAGEMENT OF OSTEOPOROSIS IN AS; BISPHOSPHONATES; ZOLEDRONIC ACID; CONCLUSION; REFERENCES; Chapter 2: EFFICACY OF ANTI-IL-6 THERAPY FOR SERONEGATIVE SPONDYLOARTHROPATHY; ABSTRACT; INTRODUCTION.
505	8		_aCASE REPORTS OF TCZ THERAPY FOR SPACASE SERIES OF TCZ THERAPY FOR SPA; RANDOMIZED CONTROL STUDY OF TCZ FOR SPA; PATHOGENIC ROLE OF IL-6 IN AN ANIMAL MODEL OF SPA; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: ANTERIOR UVEITIS IN SPONDYLOARTHROPATHY: THE OPHTHALMOLOGIST'S ROLE IN EARLIER RECOGNITION; ABSTRACT; INTRODUCTION; THE LINK BETWEEN SPA AND AAU; ACUTE ANTERIOR UVEITIS; THE BENEFITS OF EARLY DIAGNOSIS IN SPA; CONCLUSION; REFERENCES; Chapter 4: MANAGEMENT OF SPINAL FRACTURES IN ANKYLOSING SPONDYLITIS; ABSTRACT.
505	8		_aCHARACTERISTICS OF THE SPINAL FRACTURE IN ANKYLOSING SPONDYLITIS PATIENTSDIAGNOSIS; TREMATENT AND COMPLICATIONS; CASE PRESENTATIONS AND ATHOS OPINION; KEY POINTS; REFERENCES; INDEX.
590			_aMaster record variable field(s) change: 050, 650
650		0	_aAnkylosing spondylitis.
650		0	_aAnkylosis.
700	1		_aBoysen, Christine B., _eeditor.
830		0	_aMuscular system--anatomy, functions, and injuries series.
856	4	0	_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=597380 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938			_aYBP Library Services _bYANK _n10788387
938			_aEBSCOhost _bEBSC _n597380
938			_aProQuest Ebook Central _bEBLB _nEBL3022611
942			_n0
994			_a92 _bN$T
999			_c91253 _d91253